These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 20616315)

  • 21. Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy.
    Tong YF; Wang Y; Ding YY; Li JM; Pan XC; Lu XL; Chen XH; Liu Y; Zhang HG
    Cell Physiol Biochem; 2017; 42(4):1645-1656. PubMed ID: 28746924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inositol-1,4,5-trisphosphate-dependent Ca(2+) signalling in cat atrial excitation-contraction coupling and arrhythmias.
    Zima AV; Blatter LA
    J Physiol; 2004 Mar; 555(Pt 3):607-15. PubMed ID: 14754996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inositol 1,4,5-trisphosphate supports the arrhythmogenic action of endothelin-1 on ventricular cardiac myocytes.
    Proven A; Roderick HL; Conway SJ; Berridge MJ; Horton JK; Capper SJ; Bootman MD
    J Cell Sci; 2006 Aug; 119(Pt 16):3363-75. PubMed ID: 16882691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functionally redundant control of cardiac hypertrophic signaling by inositol 1,4,5-trisphosphate receptors.
    Garcia MI; Karlstaedt A; Chen JJ; Amione-Guerra J; Youker KA; Taegtmeyer H; Boehning D
    J Mol Cell Cardiol; 2017 Nov; 112():95-103. PubMed ID: 28923351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes.
    Signore S; Sorrentino A; Ferreira-Martins J; Kannappan R; Shafaie M; Del Ben F; Isobe K; Arranto C; Wybieralska E; Webster A; Sanada F; Ogórek B; Zheng H; Liu X; Del Monte F; D'Alessandro DA; Wunimenghe O; Michler RE; Hosoda T; Goichberg P; Leri A; Kajstura J; Anversa P; Rota M
    Circulation; 2013 Sep; 128(12):1286-97. PubMed ID: 23983250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Src is required for mechanical stretch-induced cardiomyocyte hypertrophy through angiotensin II type 1 receptor-dependent β-arrestin2 pathways.
    Wang S; Gong H; Jiang G; Ye Y; Wu J; You J; Zhang G; Sun A; Komuro I; Ge J; Zou Y
    PLoS One; 2014; 9(4):e92926. PubMed ID: 24699426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium sensing receptor regulates cardiomyocyte function through nuclear calcium.
    Zhong X; Liu J; Lu F; Wang Y; Zhao Y; Dong S; Leng X; Jia J; Ren H; Xu C; Zhang W
    Cell Biol Int; 2012 Oct; 36(10):937-43. PubMed ID: 22708524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
    Westenbrink BD; Ling H; Divakaruni AS; Gray CB; Zambon AC; Dalton ND; Peterson KL; Gu Y; Matkovich SJ; Murphy AN; Miyamoto S; Dorn GW; Heller Brown J
    Circ Res; 2015 Feb; 116(5):e28-39. PubMed ID: 25605649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel signaling pathway of ADP-ribosyl cyclase activation by angiotensin II in adult rat cardiomyocytes.
    Gul R; Kim SY; Park KH; Kim BJ; Kim SJ; Im MJ; Kim UH
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H77-88. PubMed ID: 18456728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted ablation of the histidine-rich Ca(2+)-binding protein (HRC) gene is associated with abnormal SR Ca(2+)-cycling and severe pathology under pressure-overload stress.
    Park CS; Chen S; Lee H; Cha H; Oh JG; Hong S; Han P; Ginsburg KS; Jin S; Park I; Singh VP; Wang HS; Franzini-Armstrong C; Park WJ; Bers DM; Kranias EG; Cho C; Kim DH
    Basic Res Cardiol; 2013 May; 108(3):344. PubMed ID: 23553082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
    Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
    Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IP
    Capel RA; Bose SJ; Collins TP; Rajasundaram S; Ayagama T; Zaccolo M; Burton RB; Terrar DA
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H95-H107. PubMed ID: 33064562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelin-1-induced arrhythmogenic Ca2+ signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate(IP3)-receptor type 2-deficient mice.
    Li X; Zima AV; Sheikh F; Blatter LA; Chen J
    Circ Res; 2005 Jun; 96(12):1274-81. PubMed ID: 15933266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition.
    Nishida M; Watanabe K; Sato Y; Nakaya M; Kitajima N; Ide T; Inoue R; Kurose H
    J Biol Chem; 2010 Apr; 285(17):13244-53. PubMed ID: 20177073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents.
    Wu X; Chang B; Blair NS; Sargent M; York AJ; Robbins J; Shull GE; Molkentin JD
    J Clin Invest; 2009 Apr; 119(4):976-85. PubMed ID: 19287093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophy.
    Drawnel FM; Wachten D; Molkentin JD; Maillet M; Aronsen JM; Swift F; Sjaastad I; Liu N; Catalucci D; Mikoshiba K; Hisatsune C; Okkenhaug H; Andrews SR; Bootman MD; Roderick HL
    J Cell Biol; 2012 Nov; 199(5):783-98. PubMed ID: 23166348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear calcineurin is a sensor for detecting Ca
    Olivares-Florez S; Czolbe M; Riediger F; Seidlmayer L; Williams T; Nordbeck P; Strasen J; Glocker C; Jänsch M; Eder-Negrin P; Arias-Loza P; Mühlfelder M; Plačkić J; Heinze KG; Molkentin JD; Engelhardt S; Kockskämper J; Ritter O
    J Mol Med (Berl); 2018 Nov; 96(11):1239-1249. PubMed ID: 30293136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gαq-mediated cell signaling.
    Li X; Chan TO; Myers V; Chowdhury I; Zhang XQ; Song J; Zhang J; Andrel J; Funakoshi H; Robbins J; Koch WJ; Hyslop T; Cheung JY; Feldman AM
    Circulation; 2011 Aug; 124(5):572-81. PubMed ID: 21747049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted expression of receptor-associated late transducer inhibits maladaptive hypertrophy via blocking epidermal growth factor receptor signaling.
    Cai J; Yi FF; Yang L; Shen DF; Yang Q; Li A; Ghosh AK; Bian ZY; Yan L; Tang QZ; Li H; Yang XC
    Hypertension; 2009 Mar; 53(3):539-48. PubMed ID: 19204184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.